Moreover, a meta-analysis with 1713 patients with breast cancer reported significant associations between SOX2 expression and increased tumor size, high tumor histological grade, increased risk of lymph node metastasis, and the highly aggressive triple-negative phenotype; nevertheless, no association was observed for TNM stage [28]. This evidence concerns the gene SOX2 and breast carcinoma.